Takeda Pharmaceutical Co Ltd (TAK)
13.37
+0.10
(+0.75%)
USD |
NYSE |
May 03, 16:00
13.36
0.00 (0.00%)
After-Hours: 20:00
Takeda Pharmaceutical Cash and Short Term Investments (Quarterly): 2.251B for Dec. 31, 2023
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 2.251B |
| September 30, 2023 | 2.235B |
| June 30, 2023 | 2.546B |
| March 31, 2023 | 4.156B |
| December 31, 2022 | 5.542B |
| September 30, 2022 | 5.746B |
| June 30, 2022 | 4.865B |
| March 31, 2022 | 7.169B |
| December 31, 2021 | 6.534B |
| September 30, 2021 | 5.660B |
| June 30, 2021 | 6.195B |
| March 31, 2021 | 9.091B |
| December 31, 2020 | 6.344B |
| September 30, 2020 | 6.115B |
| June 30, 2020 | 5.585B |
| March 31, 2020 | 6.046B |
| December 31, 2019 | 5.403B |
| September 30, 2019 | 5.164B |
| June 30, 2019 | 5.701B |
| March 31, 2019 | 6.542B |
| December 31, 2018 | 16.89B |
| September 30, 2018 | 2.967B |
| June 30, 2018 | 2.268B |
| March 31, 2018 | 3.530B |
| December 31, 2017 | 4.138B |
| Date | Value |
|---|---|
| September 30, 2017 | 4.095B |
| June 30, 2017 | 4.376B |
| March 31, 2017 | 3.364B |
| December 31, 2016 | 6.349B |
| September 30, 2016 | 7.302B |
| June 30, 2016 | 7.128B |
| March 31, 2016 | 4.983B |
| December 31, 2015 | 5.482B |
| September 30, 2015 | 5.568B |
| June 30, 2015 | 5.199B |
| March 31, 2015 | 5.944B |
| December 31, 2014 | 7.169B |
| September 30, 2014 | 7.690B |
| June 30, 2014 | 7.521B |
| March 31, 2014 | 8.269B |
| December 31, 2013 | 6.982B |
| September 30, 2013 | 7.350B |
| June 30, 2013 | 3.908B |
| March 31, 2013 | 5.967B |
| December 31, 2012 | 4.909B |
| September 30, 2012 | 5.307B |
| June 30, 2012 | 4.805B |
| March 31, 2012 | 5.595B |
| December 31, 2011 | 4.948B |
| September 30, 2011 | 5.289B |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
2.235B
Minimum
Sep 2023
9.091B
Maximum
Mar 2021
5.387B
Average
5.660B
Median
Sep 2021
Cash and Short Term Investments (Quarterly) Benchmarks
| Astellas Pharma Inc | 2.024B |
| Nxera Pharma Co Ltd | 350.16M |
| PeptiDream Inc | 138.37M |
| Stemcell Holdings Inc | 5.116M |
| Healios KK | 47.67M |